相关实验视频
Updated: Jan 16, 2026

08:17
A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
10.0K
在卵巢癌细胞中,EMSY可增强卵巢癌细胞的糖解
Shaosheng Wang1, Na Xie2, Ping Zha3
1Blood Transfusion Department, Haikou People's Hospital, Haikou, 570208, Hainan, China.
European journal of medical research
|September 30, 2025
概括
EMSY基因通过通过LDHA增加乳酸的产量来促进卵巢癌的进展. 抑制EMSY或LDHA可能为卵巢癌提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 分子生物学分子生物学
背景情况:
- EMSY基因与卵巢癌的进展有关.
- 在瘤新陈代谢中EMSY的特定作用仍然在很大程度上未被描述.
研究的目的:
- 研究EMSY对卵巢癌细胞代谢的影响.
- 阐明EMSY影响瘤行为的分子机制.
主要方法:
- 在不同EMSY水平的卵巢癌细胞中分析乳酸盐生产和LDHA表达.
- 基因淘汰实验针对LDHA和药理上抑制糖解.
- 研究EMSY和β-catenin之间的蛋白质-蛋白质相互作用.
主要成果:
- 卵巢癌细胞中EMSY过度表达与乳酸生产增加和LDHA表达升高相关.
- 抑制LDHA或抑制糖解可以抵消EMSY的亲恶性影响.
- EMSY与β-catenin直接相互作用,抑制了LDHA的转录激活.
结论:
- 在调节卵巢癌细胞的代谢活动方面,EMSY起着重要的作用.
- EMSY-β-catenin-LDHA轴代表了卵巢癌治疗的潜在治疗目标.
关键词:
在EMSYY中,你会得到一些东西.LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA LDHA 是 是 是 是 是 是 是 是 是 是 是 是 是 是 是 是卵巢癌是发生在卵巢中的癌症.这是一种β-catenin.相关概念视频
Oogenesis
69.1K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
69.1K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K

